and the data science communities.
The NCI Cancer Research Data Commons’ Genomic Data Commons (GDC) has released a new set of data from NCI programs and partners including the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the Human Cancer Models Initiative (HCMI).
The NCI Proteomic Data Commons (PDC) has new data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and the International Cancer Proteogenome Consortium (ICPC) - Taiwan Lung Adenocarcinoma (LUAD) studies. This release contains open-access proteomic data for 213 lung cancer cases.
The NCI Cancer Research Data Commons (CRDC) launched a new website, datacommons.cancer.gov, for data scientists, informaticists, and researchers to explore, learn, and engage with the CRDC and its resources.
Frederick National Laboratory for Cancer Research (FNLCR) awarded a contract to develop the National Cancer Institute's (NCI's) Cancer Data Aggregator (CDA) to a consortium led by the Broad Institute, Institute for Systems Biology, Seven Bridges Genomics, and General Dynamics Information Technology (GDIT), Inc. The CDA is a query engine that will help researchers to find, sort, and pull together data from across the NCI Cancer Research Data Commons (CRDC), NCI Data Coordinating Centers (DCC), and other repositories.
NCI’s Cancer Research Data Commons (CRDC) has added new data sets from NCI’s Clinical Proteomic Tumor Analysis Center (CPTAC), a national effort to accelerate the understanding of cancer’s molecular basis through large-scale proteome and genome analysis (a.k.a. proteogenomics).